Global AI-driven Drug Discovery Market 2023 by Company, Regions, Type and Application, Forecast to 2029
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
According to our (Global Info Research) latest study, the global AI-driven Drug Discovery market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global AI-driven Drug Discovery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global AI-driven Drug Discovery market size and forecasts, in consumption value ($ Million), 2018-2029
Global AI-driven Drug Discovery market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global AI-driven Drug Discovery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global AI-driven Drug Discovery market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-driven Drug Discovery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-driven Drug Discovery market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Entos, Selvita, Benevolent, Exscientia and Euretos, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
AI-driven Drug Discovery market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe AI-driven Drug Discovery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI-driven Drug Discovery, with revenue, gross margin and global market share of AI-driven Drug Discovery from 2018 to 2023.
Chapter 3, the AI-driven Drug Discovery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI-driven Drug Discovery market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of AI-driven Drug Discovery.
Chapter 13, to describe AI-driven Drug Discovery research findings and conclusion.
According to our (Global Info Research) latest study, the global AI-driven Drug Discovery market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global AI-driven Drug Discovery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global AI-driven Drug Discovery market size and forecasts, in consumption value ($ Million), 2018-2029
Global AI-driven Drug Discovery market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global AI-driven Drug Discovery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global AI-driven Drug Discovery market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-driven Drug Discovery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-driven Drug Discovery market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Entos, Selvita, Benevolent, Exscientia and Euretos, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
AI-driven Drug Discovery market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Small Molecule Drug
- Biological Modeling
- Structural Biology
- Others
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- Entos
- Selvita
- Benevolent
- Exscientia
- Euretos
- Illumina with AstraZeneca
- Novo Nordisk with Microsoft
- Iktos
- Aqemia
- Zephyr AI
- Cyclicarx
- Eli Lilly
- Terray Therapeutics
- Ardigen
- ReviveMed
- Insilico Medicine
- XtalPi
- MindRank
- DP Technology
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe AI-driven Drug Discovery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI-driven Drug Discovery, with revenue, gross margin and global market share of AI-driven Drug Discovery from 2018 to 2023.
Chapter 3, the AI-driven Drug Discovery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI-driven Drug Discovery market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of AI-driven Drug Discovery.
Chapter 13, to describe AI-driven Drug Discovery research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of AI-driven Drug Discovery
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI-driven Drug Discovery by Type
1.3.1 Overview: Global AI-driven Drug Discovery Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global AI-driven Drug Discovery Consumption Value Market Share by Type in 2022
1.3.3 Small Molecule Drug
1.3.4 Biological Modeling
1.3.5 Structural Biology
1.3.6 Others
1.4 Global AI-driven Drug Discovery Market by Application
1.4.1 Overview: Global AI-driven Drug Discovery Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical and Biotechnology Companies
1.4.3 Research Laboratories
1.5 Global AI-driven Drug Discovery Market Size & Forecast
1.6 Global AI-driven Drug Discovery Market Size and Forecast by Region
1.6.1 Global AI-driven Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global AI-driven Drug Discovery Market Size by Region, (2018-2029)
1.6.3 North America AI-driven Drug Discovery Market Size and Prospect (2018-2029)
1.6.4 Europe AI-driven Drug Discovery Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific AI-driven Drug Discovery Market Size and Prospect (2018-2029)
1.6.6 South America AI-driven Drug Discovery Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa AI-driven Drug Discovery Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Entos
2.1.1 Entos Details
2.1.2 Entos Major Business
2.1.3 Entos AI-driven Drug Discovery Product and Solutions
2.1.4 Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Entos Recent Developments and Future Plans
2.2 Selvita
2.2.1 Selvita Details
2.2.2 Selvita Major Business
2.2.3 Selvita AI-driven Drug Discovery Product and Solutions
2.2.4 Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Selvita Recent Developments and Future Plans
2.3 Benevolent
2.3.1 Benevolent Details
2.3.2 Benevolent Major Business
2.3.3 Benevolent AI-driven Drug Discovery Product and Solutions
2.3.4 Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Benevolent Recent Developments and Future Plans
2.4 Exscientia
2.4.1 Exscientia Details
2.4.2 Exscientia Major Business
2.4.3 Exscientia AI-driven Drug Discovery Product and Solutions
2.4.4 Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Exscientia Recent Developments and Future Plans
2.5 Euretos
2.5.1 Euretos Details
2.5.2 Euretos Major Business
2.5.3 Euretos AI-driven Drug Discovery Product and Solutions
2.5.4 Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Euretos Recent Developments and Future Plans
2.6 Illumina with AstraZeneca
2.6.1 Illumina with AstraZeneca Details
2.6.2 Illumina with AstraZeneca Major Business
2.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Product and Solutions
2.6.4 Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Illumina with AstraZeneca Recent Developments and Future Plans
2.7 Novo Nordisk with Microsoft
2.7.1 Novo Nordisk with Microsoft Details
2.7.2 Novo Nordisk with Microsoft Major Business
2.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Product and Solutions
2.7.4 Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novo Nordisk with Microsoft Recent Developments and Future Plans
2.8 Iktos
2.8.1 Iktos Details
2.8.2 Iktos Major Business
2.8.3 Iktos AI-driven Drug Discovery Product and Solutions
2.8.4 Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Iktos Recent Developments and Future Plans
2.9 Aqemia
2.9.1 Aqemia Details
2.9.2 Aqemia Major Business
2.9.3 Aqemia AI-driven Drug Discovery Product and Solutions
2.9.4 Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aqemia Recent Developments and Future Plans
2.10 Zephyr AI
2.10.1 Zephyr AI Details
2.10.2 Zephyr AI Major Business
2.10.3 Zephyr AI AI-driven Drug Discovery Product and Solutions
2.10.4 Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Zephyr AI Recent Developments and Future Plans
2.11 Cyclicarx
2.11.1 Cyclicarx Details
2.11.2 Cyclicarx Major Business
2.11.3 Cyclicarx AI-driven Drug Discovery Product and Solutions
2.11.4 Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cyclicarx Recent Developments and Future Plans
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business
2.12.3 Eli Lilly AI-driven Drug Discovery Product and Solutions
2.12.4 Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Eli Lilly Recent Developments and Future Plans
2.13 Terray Therapeutics
2.13.1 Terray Therapeutics Details
2.13.2 Terray Therapeutics Major Business
2.13.3 Terray Therapeutics AI-driven Drug Discovery Product and Solutions
2.13.4 Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Terray Therapeutics Recent Developments and Future Plans
2.14 Ardigen
2.14.1 Ardigen Details
2.14.2 Ardigen Major Business
2.14.3 Ardigen AI-driven Drug Discovery Product and Solutions
2.14.4 Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Ardigen Recent Developments and Future Plans
2.15 ReviveMed
2.15.1 ReviveMed Details
2.15.2 ReviveMed Major Business
2.15.3 ReviveMed AI-driven Drug Discovery Product and Solutions
2.15.4 ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 ReviveMed Recent Developments and Future Plans
2.16 Insilico Medicine
2.16.1 Insilico Medicine Details
2.16.2 Insilico Medicine Major Business
2.16.3 Insilico Medicine AI-driven Drug Discovery Product and Solutions
2.16.4 Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Insilico Medicine Recent Developments and Future Plans
2.17 XtalPi
2.17.1 XtalPi Details
2.17.2 XtalPi Major Business
2.17.3 XtalPi AI-driven Drug Discovery Product and Solutions
2.17.4 XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 XtalPi Recent Developments and Future Plans
2.18 MindRank
2.18.1 MindRank Details
2.18.2 MindRank Major Business
2.18.3 MindRank AI-driven Drug Discovery Product and Solutions
2.18.4 MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 MindRank Recent Developments and Future Plans
2.19 DP Technology
2.19.1 DP Technology Details
2.19.2 DP Technology Major Business
2.19.3 DP Technology AI-driven Drug Discovery Product and Solutions
2.19.4 DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 DP Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI-driven Drug Discovery Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of AI-driven Drug Discovery by Company Revenue
3.2.2 Top 3 AI-driven Drug Discovery Players Market Share in 2022
3.2.3 Top 6 AI-driven Drug Discovery Players Market Share in 2022
3.3 AI-driven Drug Discovery Market: Overall Company Footprint Analysis
3.3.1 AI-driven Drug Discovery Market: Region Footprint
3.3.2 AI-driven Drug Discovery Market: Company Product Type Footprint
3.3.3 AI-driven Drug Discovery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI-driven Drug Discovery Consumption Value and Market Share by Type (2018-2023)
4.2 Global AI-driven Drug Discovery Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2023)
5.2 Global AI-driven Drug Discovery Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America AI-driven Drug Discovery Consumption Value by Type (2018-2029)
6.2 North America AI-driven Drug Discovery Consumption Value by Application (2018-2029)
6.3 North America AI-driven Drug Discovery Market Size by Country
6.3.1 North America AI-driven Drug Discovery Consumption Value by Country (2018-2029)
6.3.2 United States AI-driven Drug Discovery Market Size and Forecast (2018-2029)
6.3.3 Canada AI-driven Drug Discovery Market Size and Forecast (2018-2029)
6.3.4 Mexico AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe AI-driven Drug Discovery Consumption Value by Type (2018-2029)
7.2 Europe AI-driven Drug Discovery Consumption Value by Application (2018-2029)
7.3 Europe AI-driven Drug Discovery Market Size by Country
7.3.1 Europe AI-driven Drug Discovery Consumption Value by Country (2018-2029)
7.3.2 Germany AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7.3.3 France AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7.3.4 United Kingdom AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7.3.5 Russia AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7.3.6 Italy AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI-driven Drug Discovery Consumption Value by Type (2018-2029)
8.2 Asia-Pacific AI-driven Drug Discovery Consumption Value by Application (2018-2029)
8.3 Asia-Pacific AI-driven Drug Discovery Market Size by Region
8.3.1 Asia-Pacific AI-driven Drug Discovery Consumption Value by Region (2018-2029)
8.3.2 China AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.3 Japan AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.4 South Korea AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.5 India AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.7 Australia AI-driven Drug Discovery Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America AI-driven Drug Discovery Consumption Value by Type (2018-2029)
9.2 South America AI-driven Drug Discovery Consumption Value by Application (2018-2029)
9.3 South America AI-driven Drug Discovery Market Size by Country
9.3.1 South America AI-driven Drug Discovery Consumption Value by Country (2018-2029)
9.3.2 Brazil AI-driven Drug Discovery Market Size and Forecast (2018-2029)
9.3.3 Argentina AI-driven Drug Discovery Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI-driven Drug Discovery Consumption Value by Type (2018-2029)
10.2 Middle East & Africa AI-driven Drug Discovery Consumption Value by Application (2018-2029)
10.3 Middle East & Africa AI-driven Drug Discovery Market Size by Country
10.3.1 Middle East & Africa AI-driven Drug Discovery Consumption Value by Country (2018-2029)
10.3.2 Turkey AI-driven Drug Discovery Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia AI-driven Drug Discovery Market Size and Forecast (2018-2029)
10.3.4 UAE AI-driven Drug Discovery Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 AI-driven Drug Discovery Market Drivers
11.2 AI-driven Drug Discovery Market Restraints
11.3 AI-driven Drug Discovery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 AI-driven Drug Discovery Industry Chain
12.2 AI-driven Drug Discovery Upstream Analysis
12.3 AI-driven Drug Discovery Midstream Analysis
12.4 AI-driven Drug Discovery Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of AI-driven Drug Discovery
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI-driven Drug Discovery by Type
1.3.1 Overview: Global AI-driven Drug Discovery Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global AI-driven Drug Discovery Consumption Value Market Share by Type in 2022
1.3.3 Small Molecule Drug
1.3.4 Biological Modeling
1.3.5 Structural Biology
1.3.6 Others
1.4 Global AI-driven Drug Discovery Market by Application
1.4.1 Overview: Global AI-driven Drug Discovery Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical and Biotechnology Companies
1.4.3 Research Laboratories
1.5 Global AI-driven Drug Discovery Market Size & Forecast
1.6 Global AI-driven Drug Discovery Market Size and Forecast by Region
1.6.1 Global AI-driven Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global AI-driven Drug Discovery Market Size by Region, (2018-2029)
1.6.3 North America AI-driven Drug Discovery Market Size and Prospect (2018-2029)
1.6.4 Europe AI-driven Drug Discovery Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific AI-driven Drug Discovery Market Size and Prospect (2018-2029)
1.6.6 South America AI-driven Drug Discovery Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa AI-driven Drug Discovery Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Entos
2.1.1 Entos Details
2.1.2 Entos Major Business
2.1.3 Entos AI-driven Drug Discovery Product and Solutions
2.1.4 Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Entos Recent Developments and Future Plans
2.2 Selvita
2.2.1 Selvita Details
2.2.2 Selvita Major Business
2.2.3 Selvita AI-driven Drug Discovery Product and Solutions
2.2.4 Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Selvita Recent Developments and Future Plans
2.3 Benevolent
2.3.1 Benevolent Details
2.3.2 Benevolent Major Business
2.3.3 Benevolent AI-driven Drug Discovery Product and Solutions
2.3.4 Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Benevolent Recent Developments and Future Plans
2.4 Exscientia
2.4.1 Exscientia Details
2.4.2 Exscientia Major Business
2.4.3 Exscientia AI-driven Drug Discovery Product and Solutions
2.4.4 Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Exscientia Recent Developments and Future Plans
2.5 Euretos
2.5.1 Euretos Details
2.5.2 Euretos Major Business
2.5.3 Euretos AI-driven Drug Discovery Product and Solutions
2.5.4 Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Euretos Recent Developments and Future Plans
2.6 Illumina with AstraZeneca
2.6.1 Illumina with AstraZeneca Details
2.6.2 Illumina with AstraZeneca Major Business
2.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Product and Solutions
2.6.4 Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Illumina with AstraZeneca Recent Developments and Future Plans
2.7 Novo Nordisk with Microsoft
2.7.1 Novo Nordisk with Microsoft Details
2.7.2 Novo Nordisk with Microsoft Major Business
2.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Product and Solutions
2.7.4 Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novo Nordisk with Microsoft Recent Developments and Future Plans
2.8 Iktos
2.8.1 Iktos Details
2.8.2 Iktos Major Business
2.8.3 Iktos AI-driven Drug Discovery Product and Solutions
2.8.4 Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Iktos Recent Developments and Future Plans
2.9 Aqemia
2.9.1 Aqemia Details
2.9.2 Aqemia Major Business
2.9.3 Aqemia AI-driven Drug Discovery Product and Solutions
2.9.4 Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aqemia Recent Developments and Future Plans
2.10 Zephyr AI
2.10.1 Zephyr AI Details
2.10.2 Zephyr AI Major Business
2.10.3 Zephyr AI AI-driven Drug Discovery Product and Solutions
2.10.4 Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Zephyr AI Recent Developments and Future Plans
2.11 Cyclicarx
2.11.1 Cyclicarx Details
2.11.2 Cyclicarx Major Business
2.11.3 Cyclicarx AI-driven Drug Discovery Product and Solutions
2.11.4 Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cyclicarx Recent Developments and Future Plans
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business
2.12.3 Eli Lilly AI-driven Drug Discovery Product and Solutions
2.12.4 Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Eli Lilly Recent Developments and Future Plans
2.13 Terray Therapeutics
2.13.1 Terray Therapeutics Details
2.13.2 Terray Therapeutics Major Business
2.13.3 Terray Therapeutics AI-driven Drug Discovery Product and Solutions
2.13.4 Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Terray Therapeutics Recent Developments and Future Plans
2.14 Ardigen
2.14.1 Ardigen Details
2.14.2 Ardigen Major Business
2.14.3 Ardigen AI-driven Drug Discovery Product and Solutions
2.14.4 Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Ardigen Recent Developments and Future Plans
2.15 ReviveMed
2.15.1 ReviveMed Details
2.15.2 ReviveMed Major Business
2.15.3 ReviveMed AI-driven Drug Discovery Product and Solutions
2.15.4 ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 ReviveMed Recent Developments and Future Plans
2.16 Insilico Medicine
2.16.1 Insilico Medicine Details
2.16.2 Insilico Medicine Major Business
2.16.3 Insilico Medicine AI-driven Drug Discovery Product and Solutions
2.16.4 Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Insilico Medicine Recent Developments and Future Plans
2.17 XtalPi
2.17.1 XtalPi Details
2.17.2 XtalPi Major Business
2.17.3 XtalPi AI-driven Drug Discovery Product and Solutions
2.17.4 XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 XtalPi Recent Developments and Future Plans
2.18 MindRank
2.18.1 MindRank Details
2.18.2 MindRank Major Business
2.18.3 MindRank AI-driven Drug Discovery Product and Solutions
2.18.4 MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 MindRank Recent Developments and Future Plans
2.19 DP Technology
2.19.1 DP Technology Details
2.19.2 DP Technology Major Business
2.19.3 DP Technology AI-driven Drug Discovery Product and Solutions
2.19.4 DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 DP Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI-driven Drug Discovery Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of AI-driven Drug Discovery by Company Revenue
3.2.2 Top 3 AI-driven Drug Discovery Players Market Share in 2022
3.2.3 Top 6 AI-driven Drug Discovery Players Market Share in 2022
3.3 AI-driven Drug Discovery Market: Overall Company Footprint Analysis
3.3.1 AI-driven Drug Discovery Market: Region Footprint
3.3.2 AI-driven Drug Discovery Market: Company Product Type Footprint
3.3.3 AI-driven Drug Discovery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI-driven Drug Discovery Consumption Value and Market Share by Type (2018-2023)
4.2 Global AI-driven Drug Discovery Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2023)
5.2 Global AI-driven Drug Discovery Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America AI-driven Drug Discovery Consumption Value by Type (2018-2029)
6.2 North America AI-driven Drug Discovery Consumption Value by Application (2018-2029)
6.3 North America AI-driven Drug Discovery Market Size by Country
6.3.1 North America AI-driven Drug Discovery Consumption Value by Country (2018-2029)
6.3.2 United States AI-driven Drug Discovery Market Size and Forecast (2018-2029)
6.3.3 Canada AI-driven Drug Discovery Market Size and Forecast (2018-2029)
6.3.4 Mexico AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe AI-driven Drug Discovery Consumption Value by Type (2018-2029)
7.2 Europe AI-driven Drug Discovery Consumption Value by Application (2018-2029)
7.3 Europe AI-driven Drug Discovery Market Size by Country
7.3.1 Europe AI-driven Drug Discovery Consumption Value by Country (2018-2029)
7.3.2 Germany AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7.3.3 France AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7.3.4 United Kingdom AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7.3.5 Russia AI-driven Drug Discovery Market Size and Forecast (2018-2029)
7.3.6 Italy AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI-driven Drug Discovery Consumption Value by Type (2018-2029)
8.2 Asia-Pacific AI-driven Drug Discovery Consumption Value by Application (2018-2029)
8.3 Asia-Pacific AI-driven Drug Discovery Market Size by Region
8.3.1 Asia-Pacific AI-driven Drug Discovery Consumption Value by Region (2018-2029)
8.3.2 China AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.3 Japan AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.4 South Korea AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.5 India AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia AI-driven Drug Discovery Market Size and Forecast (2018-2029)
8.3.7 Australia AI-driven Drug Discovery Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America AI-driven Drug Discovery Consumption Value by Type (2018-2029)
9.2 South America AI-driven Drug Discovery Consumption Value by Application (2018-2029)
9.3 South America AI-driven Drug Discovery Market Size by Country
9.3.1 South America AI-driven Drug Discovery Consumption Value by Country (2018-2029)
9.3.2 Brazil AI-driven Drug Discovery Market Size and Forecast (2018-2029)
9.3.3 Argentina AI-driven Drug Discovery Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI-driven Drug Discovery Consumption Value by Type (2018-2029)
10.2 Middle East & Africa AI-driven Drug Discovery Consumption Value by Application (2018-2029)
10.3 Middle East & Africa AI-driven Drug Discovery Market Size by Country
10.3.1 Middle East & Africa AI-driven Drug Discovery Consumption Value by Country (2018-2029)
10.3.2 Turkey AI-driven Drug Discovery Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia AI-driven Drug Discovery Market Size and Forecast (2018-2029)
10.3.4 UAE AI-driven Drug Discovery Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 AI-driven Drug Discovery Market Drivers
11.2 AI-driven Drug Discovery Market Restraints
11.3 AI-driven Drug Discovery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 AI-driven Drug Discovery Industry Chain
12.2 AI-driven Drug Discovery Upstream Analysis
12.3 AI-driven Drug Discovery Midstream Analysis
12.4 AI-driven Drug Discovery Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AI-driven Drug Discovery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global AI-driven Drug Discovery Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global AI-driven Drug Discovery Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global AI-driven Drug Discovery Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Entos Company Information, Head Office, and Major Competitors
Table 6. Entos Major Business
Table 7. Entos AI-driven Drug Discovery Product and Solutions
Table 8. Entos AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Entos Recent Developments and Future Plans
Table 10. Selvita Company Information, Head Office, and Major Competitors
Table 11. Selvita Major Business
Table 12. Selvita AI-driven Drug Discovery Product and Solutions
Table 13. Selvita AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Selvita Recent Developments and Future Plans
Table 15. Benevolent Company Information, Head Office, and Major Competitors
Table 16. Benevolent Major Business
Table 17. Benevolent AI-driven Drug Discovery Product and Solutions
Table 18. Benevolent AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Benevolent Recent Developments and Future Plans
Table 20. Exscientia Company Information, Head Office, and Major Competitors
Table 21. Exscientia Major Business
Table 22. Exscientia AI-driven Drug Discovery Product and Solutions
Table 23. Exscientia AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Exscientia Recent Developments and Future Plans
Table 25. Euretos Company Information, Head Office, and Major Competitors
Table 26. Euretos Major Business
Table 27. Euretos AI-driven Drug Discovery Product and Solutions
Table 28. Euretos AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Euretos Recent Developments and Future Plans
Table 30. Illumina with AstraZeneca Company Information, Head Office, and Major Competitors
Table 31. Illumina with AstraZeneca Major Business
Table 32. Illumina with AstraZeneca AI-driven Drug Discovery Product and Solutions
Table 33. Illumina with AstraZeneca AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Illumina with AstraZeneca Recent Developments and Future Plans
Table 35. Novo Nordisk with Microsoft Company Information, Head Office, and Major Competitors
Table 36. Novo Nordisk with Microsoft Major Business
Table 37. Novo Nordisk with Microsoft AI-driven Drug Discovery Product and Solutions
Table 38. Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Novo Nordisk with Microsoft Recent Developments and Future Plans
Table 40. Iktos Company Information, Head Office, and Major Competitors
Table 41. Iktos Major Business
Table 42. Iktos AI-driven Drug Discovery Product and Solutions
Table 43. Iktos AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Iktos Recent Developments and Future Plans
Table 45. Aqemia Company Information, Head Office, and Major Competitors
Table 46. Aqemia Major Business
Table 47. Aqemia AI-driven Drug Discovery Product and Solutions
Table 48. Aqemia AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Aqemia Recent Developments and Future Plans
Table 50. Zephyr AI Company Information, Head Office, and Major Competitors
Table 51. Zephyr AI Major Business
Table 52. Zephyr AI AI-driven Drug Discovery Product and Solutions
Table 53. Zephyr AI AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Zephyr AI Recent Developments and Future Plans
Table 55. Cyclicarx Company Information, Head Office, and Major Competitors
Table 56. Cyclicarx Major Business
Table 57. Cyclicarx AI-driven Drug Discovery Product and Solutions
Table 58. Cyclicarx AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Cyclicarx Recent Developments and Future Plans
Table 60. Eli Lilly Company Information, Head Office, and Major Competitors
Table 61. Eli Lilly Major Business
Table 62. Eli Lilly AI-driven Drug Discovery Product and Solutions
Table 63. Eli Lilly AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Eli Lilly Recent Developments and Future Plans
Table 65. Terray Therapeutics Company Information, Head Office, and Major Competitors
Table 66. Terray Therapeutics Major Business
Table 67. Terray Therapeutics AI-driven Drug Discovery Product and Solutions
Table 68. Terray Therapeutics AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Terray Therapeutics Recent Developments and Future Plans
Table 70. Ardigen Company Information, Head Office, and Major Competitors
Table 71. Ardigen Major Business
Table 72. Ardigen AI-driven Drug Discovery Product and Solutions
Table 73. Ardigen AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Ardigen Recent Developments and Future Plans
Table 75. ReviveMed Company Information, Head Office, and Major Competitors
Table 76. ReviveMed Major Business
Table 77. ReviveMed AI-driven Drug Discovery Product and Solutions
Table 78. ReviveMed AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. ReviveMed Recent Developments and Future Plans
Table 80. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 81. Insilico Medicine Major Business
Table 82. Insilico Medicine AI-driven Drug Discovery Product and Solutions
Table 83. Insilico Medicine AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Insilico Medicine Recent Developments and Future Plans
Table 85. XtalPi Company Information, Head Office, and Major Competitors
Table 86. XtalPi Major Business
Table 87. XtalPi AI-driven Drug Discovery Product and Solutions
Table 88. XtalPi AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. XtalPi Recent Developments and Future Plans
Table 90. MindRank Company Information, Head Office, and Major Competitors
Table 91. MindRank Major Business
Table 92. MindRank AI-driven Drug Discovery Product and Solutions
Table 93. MindRank AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. MindRank Recent Developments and Future Plans
Table 95. DP Technology Company Information, Head Office, and Major Competitors
Table 96. DP Technology Major Business
Table 97. DP Technology AI-driven Drug Discovery Product and Solutions
Table 98. DP Technology AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. DP Technology Recent Developments and Future Plans
Table 100. Global AI-driven Drug Discovery Revenue (USD Million) by Players (2018-2023)
Table 101. Global AI-driven Drug Discovery Revenue Share by Players (2018-2023)
Table 102. Breakdown of AI-driven Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in AI-driven Drug Discovery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key AI-driven Drug Discovery Players
Table 105. AI-driven Drug Discovery Market: Company Product Type Footprint
Table 106. AI-driven Drug Discovery Market: Company Product Application Footprint
Table 107. AI-driven Drug Discovery New Market Entrants and Barriers to Market Entry
Table 108. AI-driven Drug Discovery Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global AI-driven Drug Discovery Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global AI-driven Drug Discovery Consumption Value Share by Type (2018-2023)
Table 111. Global AI-driven Drug Discovery Consumption Value Forecast by Type (2024-2029)
Table 112. Global AI-driven Drug Discovery Consumption Value by Application (2018-2023)
Table 113. Global AI-driven Drug Discovery Consumption Value Forecast by Application (2024-2029)
Table 114. North America AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America AI-driven Drug Discovery Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America AI-driven Drug Discovery Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe AI-driven Drug Discovery Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe AI-driven Drug Discovery Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific AI-driven Drug Discovery Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific AI-driven Drug Discovery Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America AI-driven Drug Discovery Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America AI-driven Drug Discovery Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa AI-driven Drug Discovery Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa AI-driven Drug Discovery Consumption Value by Country (2024-2029) & (USD Million)
Table 144. AI-driven Drug Discovery Raw Material
Table 145. Key Suppliers of AI-driven Drug Discovery Raw Materials
Table 1. Global AI-driven Drug Discovery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global AI-driven Drug Discovery Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global AI-driven Drug Discovery Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global AI-driven Drug Discovery Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Entos Company Information, Head Office, and Major Competitors
Table 6. Entos Major Business
Table 7. Entos AI-driven Drug Discovery Product and Solutions
Table 8. Entos AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Entos Recent Developments and Future Plans
Table 10. Selvita Company Information, Head Office, and Major Competitors
Table 11. Selvita Major Business
Table 12. Selvita AI-driven Drug Discovery Product and Solutions
Table 13. Selvita AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Selvita Recent Developments and Future Plans
Table 15. Benevolent Company Information, Head Office, and Major Competitors
Table 16. Benevolent Major Business
Table 17. Benevolent AI-driven Drug Discovery Product and Solutions
Table 18. Benevolent AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Benevolent Recent Developments and Future Plans
Table 20. Exscientia Company Information, Head Office, and Major Competitors
Table 21. Exscientia Major Business
Table 22. Exscientia AI-driven Drug Discovery Product and Solutions
Table 23. Exscientia AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Exscientia Recent Developments and Future Plans
Table 25. Euretos Company Information, Head Office, and Major Competitors
Table 26. Euretos Major Business
Table 27. Euretos AI-driven Drug Discovery Product and Solutions
Table 28. Euretos AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Euretos Recent Developments and Future Plans
Table 30. Illumina with AstraZeneca Company Information, Head Office, and Major Competitors
Table 31. Illumina with AstraZeneca Major Business
Table 32. Illumina with AstraZeneca AI-driven Drug Discovery Product and Solutions
Table 33. Illumina with AstraZeneca AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Illumina with AstraZeneca Recent Developments and Future Plans
Table 35. Novo Nordisk with Microsoft Company Information, Head Office, and Major Competitors
Table 36. Novo Nordisk with Microsoft Major Business
Table 37. Novo Nordisk with Microsoft AI-driven Drug Discovery Product and Solutions
Table 38. Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Novo Nordisk with Microsoft Recent Developments and Future Plans
Table 40. Iktos Company Information, Head Office, and Major Competitors
Table 41. Iktos Major Business
Table 42. Iktos AI-driven Drug Discovery Product and Solutions
Table 43. Iktos AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Iktos Recent Developments and Future Plans
Table 45. Aqemia Company Information, Head Office, and Major Competitors
Table 46. Aqemia Major Business
Table 47. Aqemia AI-driven Drug Discovery Product and Solutions
Table 48. Aqemia AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Aqemia Recent Developments and Future Plans
Table 50. Zephyr AI Company Information, Head Office, and Major Competitors
Table 51. Zephyr AI Major Business
Table 52. Zephyr AI AI-driven Drug Discovery Product and Solutions
Table 53. Zephyr AI AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Zephyr AI Recent Developments and Future Plans
Table 55. Cyclicarx Company Information, Head Office, and Major Competitors
Table 56. Cyclicarx Major Business
Table 57. Cyclicarx AI-driven Drug Discovery Product and Solutions
Table 58. Cyclicarx AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Cyclicarx Recent Developments and Future Plans
Table 60. Eli Lilly Company Information, Head Office, and Major Competitors
Table 61. Eli Lilly Major Business
Table 62. Eli Lilly AI-driven Drug Discovery Product and Solutions
Table 63. Eli Lilly AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Eli Lilly Recent Developments and Future Plans
Table 65. Terray Therapeutics Company Information, Head Office, and Major Competitors
Table 66. Terray Therapeutics Major Business
Table 67. Terray Therapeutics AI-driven Drug Discovery Product and Solutions
Table 68. Terray Therapeutics AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Terray Therapeutics Recent Developments and Future Plans
Table 70. Ardigen Company Information, Head Office, and Major Competitors
Table 71. Ardigen Major Business
Table 72. Ardigen AI-driven Drug Discovery Product and Solutions
Table 73. Ardigen AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Ardigen Recent Developments and Future Plans
Table 75. ReviveMed Company Information, Head Office, and Major Competitors
Table 76. ReviveMed Major Business
Table 77. ReviveMed AI-driven Drug Discovery Product and Solutions
Table 78. ReviveMed AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. ReviveMed Recent Developments and Future Plans
Table 80. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 81. Insilico Medicine Major Business
Table 82. Insilico Medicine AI-driven Drug Discovery Product and Solutions
Table 83. Insilico Medicine AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Insilico Medicine Recent Developments and Future Plans
Table 85. XtalPi Company Information, Head Office, and Major Competitors
Table 86. XtalPi Major Business
Table 87. XtalPi AI-driven Drug Discovery Product and Solutions
Table 88. XtalPi AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. XtalPi Recent Developments and Future Plans
Table 90. MindRank Company Information, Head Office, and Major Competitors
Table 91. MindRank Major Business
Table 92. MindRank AI-driven Drug Discovery Product and Solutions
Table 93. MindRank AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. MindRank Recent Developments and Future Plans
Table 95. DP Technology Company Information, Head Office, and Major Competitors
Table 96. DP Technology Major Business
Table 97. DP Technology AI-driven Drug Discovery Product and Solutions
Table 98. DP Technology AI-driven Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. DP Technology Recent Developments and Future Plans
Table 100. Global AI-driven Drug Discovery Revenue (USD Million) by Players (2018-2023)
Table 101. Global AI-driven Drug Discovery Revenue Share by Players (2018-2023)
Table 102. Breakdown of AI-driven Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in AI-driven Drug Discovery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key AI-driven Drug Discovery Players
Table 105. AI-driven Drug Discovery Market: Company Product Type Footprint
Table 106. AI-driven Drug Discovery Market: Company Product Application Footprint
Table 107. AI-driven Drug Discovery New Market Entrants and Barriers to Market Entry
Table 108. AI-driven Drug Discovery Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global AI-driven Drug Discovery Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global AI-driven Drug Discovery Consumption Value Share by Type (2018-2023)
Table 111. Global AI-driven Drug Discovery Consumption Value Forecast by Type (2024-2029)
Table 112. Global AI-driven Drug Discovery Consumption Value by Application (2018-2023)
Table 113. Global AI-driven Drug Discovery Consumption Value Forecast by Application (2024-2029)
Table 114. North America AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America AI-driven Drug Discovery Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America AI-driven Drug Discovery Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe AI-driven Drug Discovery Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe AI-driven Drug Discovery Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific AI-driven Drug Discovery Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific AI-driven Drug Discovery Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America AI-driven Drug Discovery Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America AI-driven Drug Discovery Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa AI-driven Drug Discovery Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa AI-driven Drug Discovery Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa AI-driven Drug Discovery Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa AI-driven Drug Discovery Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa AI-driven Drug Discovery Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa AI-driven Drug Discovery Consumption Value by Country (2024-2029) & (USD Million)
Table 144. AI-driven Drug Discovery Raw Material
Table 145. Key Suppliers of AI-driven Drug Discovery Raw Materials
LIST OF FIGURES
Figure 1. AI-driven Drug Discovery Picture
Figure 2. Global AI-driven Drug Discovery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global AI-driven Drug Discovery Consumption Value Market Share by Type in 2022
Figure 4. Small Molecule Drug
Figure 5. Biological Modeling
Figure 6. Structural Biology
Figure 7. Others
Figure 8. Global AI-driven Drug Discovery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. AI-driven Drug Discovery Consumption Value Market Share by Application in 2022
Figure 10. Pharmaceutical and Biotechnology Companies Picture
Figure 11. Research Laboratories Picture
Figure 12. Global AI-driven Drug Discovery Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global AI-driven Drug Discovery Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market AI-driven Drug Discovery Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global AI-driven Drug Discovery Consumption Value Market Share by Region (2018-2029)
Figure 16. Global AI-driven Drug Discovery Consumption Value Market Share by Region in 2022
Figure 17. North America AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 20. South America AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 22. Global AI-driven Drug Discovery Revenue Share by Players in 2022
Figure 23. AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players AI-driven Drug Discovery Market Share in 2022
Figure 25. Global Top 6 Players AI-driven Drug Discovery Market Share in 2022
Figure 26. Global AI-driven Drug Discovery Consumption Value Share by Type (2018-2023)
Figure 27. Global AI-driven Drug Discovery Market Share Forecast by Type (2024-2029)
Figure 28. Global AI-driven Drug Discovery Consumption Value Share by Application (2018-2023)
Figure 29. Global AI-driven Drug Discovery Market Share Forecast by Application (2024-2029)
Figure 30. North America AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 31. North America AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 32. North America AI-driven Drug Discovery Consumption Value Market Share by Country (2018-2029)
Figure 33. United States AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe AI-driven Drug Discovery Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 40. France AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific AI-driven Drug Discovery Consumption Value Market Share by Region (2018-2029)
Figure 47. China AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 50. India AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 53. South America AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 54. South America AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 55. South America AI-driven Drug Discovery Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa AI-driven Drug Discovery Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 64. AI-driven Drug Discovery Market Drivers
Figure 65. AI-driven Drug Discovery Market Restraints
Figure 66. AI-driven Drug Discovery Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of AI-driven Drug Discovery in 2022
Figure 69. Manufacturing Process Analysis of AI-driven Drug Discovery
Figure 70. AI-driven Drug Discovery Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. AI-driven Drug Discovery Picture
Figure 2. Global AI-driven Drug Discovery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global AI-driven Drug Discovery Consumption Value Market Share by Type in 2022
Figure 4. Small Molecule Drug
Figure 5. Biological Modeling
Figure 6. Structural Biology
Figure 7. Others
Figure 8. Global AI-driven Drug Discovery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. AI-driven Drug Discovery Consumption Value Market Share by Application in 2022
Figure 10. Pharmaceutical and Biotechnology Companies Picture
Figure 11. Research Laboratories Picture
Figure 12. Global AI-driven Drug Discovery Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global AI-driven Drug Discovery Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market AI-driven Drug Discovery Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global AI-driven Drug Discovery Consumption Value Market Share by Region (2018-2029)
Figure 16. Global AI-driven Drug Discovery Consumption Value Market Share by Region in 2022
Figure 17. North America AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 20. South America AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 22. Global AI-driven Drug Discovery Revenue Share by Players in 2022
Figure 23. AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players AI-driven Drug Discovery Market Share in 2022
Figure 25. Global Top 6 Players AI-driven Drug Discovery Market Share in 2022
Figure 26. Global AI-driven Drug Discovery Consumption Value Share by Type (2018-2023)
Figure 27. Global AI-driven Drug Discovery Market Share Forecast by Type (2024-2029)
Figure 28. Global AI-driven Drug Discovery Consumption Value Share by Application (2018-2023)
Figure 29. Global AI-driven Drug Discovery Market Share Forecast by Application (2024-2029)
Figure 30. North America AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 31. North America AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 32. North America AI-driven Drug Discovery Consumption Value Market Share by Country (2018-2029)
Figure 33. United States AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe AI-driven Drug Discovery Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 40. France AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific AI-driven Drug Discovery Consumption Value Market Share by Region (2018-2029)
Figure 47. China AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 50. India AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 53. South America AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 54. South America AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 55. South America AI-driven Drug Discovery Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa AI-driven Drug Discovery Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa AI-driven Drug Discovery Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa AI-driven Drug Discovery Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 64. AI-driven Drug Discovery Market Drivers
Figure 65. AI-driven Drug Discovery Market Restraints
Figure 66. AI-driven Drug Discovery Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of AI-driven Drug Discovery in 2022
Figure 69. Manufacturing Process Analysis of AI-driven Drug Discovery
Figure 70. AI-driven Drug Discovery Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
